Paragon Care Ltd (ASX: PGC) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Paragon Care Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$248.30 million
P/E Ratio
15.32
Dividend Yield
0.00%
Shares Outstanding
1.66 billion
Earnings per share
-0.010
Dividend per share
0.01
Year To Date Return
-30.23%
Earnings Yield
6.53%
Franking
100%
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Paragon Care Ltd (ASX: PGC)
Latest News
Earnings Results
Paragon Care (ASX: PGC) share price soars 5% on $8.3 million profit
ASX Share Market News
ASX winners and losers from the Victorian budget
ASX Share Market News
Here's why the Paragon (ASX:PGC) share price has surged 19% today
Healthcare Shares
Why the Paragon Care share price is rocketing 83% today
ASX Share Market News
Why these 3 ASX shares surged higher today
Share Fallers
Why ARB, OneVue, Origin Energy, & Paragon Care are tumbling lower
ASX Share Market News
Why the Paragon share price has plummeted 19% today
Defensive Shares
3 healthcare ASX shares I'd buy for my portfolio
Growth Shares
3 ASX healthcare shares to buy for a healthy portfolio
Share Fallers
Why Bubs, Incitec Pivot, Paragon Care, & Slater & Gordon shares dropped lower today
Defensive Shares
2 ASX healthcare shares on my buy radar
⏸️ ASX Shares
3 ASX shares I'd buy for 2020 and beyond
Dividend Payment History Data provided by Morningstar.
| Ex-Date | Amount | Franking | Type | Payable |
|---|---|---|---|---|
| 18 Sep 2023 | $0.0060 | 100.00% | Final | 06 Oct 2023 |
| 14 Mar 2023 | $0.0060 | 100.00% | Interim | 05 Apr 2023 |
| 12 Sep 2022 | $0.0060 | 100.00% | Final | 04 Oct 2022 |
| 21 Mar 2022 | $0.0060 | 100.00% | Interim | 26 Apr 2022 |
| 13 Sep 2021 | $0.0100 | 100.00% | Final | 01 Oct 2021 |
| 21 Mar 2019 | $0.0110 | 100.00% | Interim | 26 Apr 2019 |
| 14 Sep 2018 | $0.0200 | 100.00% | Final | 12 Oct 2018 |
| 15 Mar 2018 | $0.0110 | 100.00% | Interim | 12 Apr 2018 |
| 07 Sep 2017 | $0.0000 | 100.00% | Final | 06 Oct 2017 |
| 09 Mar 2017 | $0.0110 | 100.00% | Interim | 06 Apr 2017 |
| 15 Sep 2016 | $0.0140 | 100.00% | Final | 06 Oct 2016 |
| 09 Mar 2016 | $0.0080 | 100.00% | Interim | 06 Apr 2016 |
| 08 Oct 2014 | $0.0075 | 100.00% | Final | 31 Oct 2014 |
| 07 Mar 2014 | $0.0050 | 100.00% | Interim | 31 Mar 2014 |
| 04 Oct 2013 | $0.0100 | 100.00% | Final | 31 Oct 2013 |
PGC ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Paragon Care Ltd
Paragon Care Ltd. engages in supplying medical equipment to the health and aged care markets. Its product categories include balance and mobility, beds, mattresses and furniture, carts and trolleys, consulting room equipment, dermatology and cosmetic medicine, general medical products, consumables, infection control, lighting, materials management, newborn care, operating theatre, and ophthalmic. The company was founded in 1994 and is headquartered in South Melbourne, Australia.
PGC Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 22 Oct 2026 | $0.15 | $0.00 | 0.00% | 616,331 | $0.15 | $0.15 | $0.15 |
| 21 Oct 2026 | $0.15 | $0.00 | 0.00% | 341,838 | $0.15 | $0.16 | $0.15 |
| 20 Oct 2026 | $0.15 | $0.00 | 0.00% | 506,362 | $0.15 | $0.15 | $0.15 |
| 19 Oct 2026 | $0.15 | $0.01 | 6.90% | 1,074,846 | $0.15 | $0.16 | $0.15 |
| 16 Oct 2026 | $0.15 | $-0.01 | -6.67% | 346,940 | $0.15 | $0.15 | $0.14 |
| 15 Oct 2026 | $0.15 | $0.01 | 6.90% | 676,605 | $0.15 | $0.15 | $0.14 |
| 14 Oct 2026 | $0.15 | $0.00 | 0.00% | 555,478 | $0.15 | $0.15 | $0.14 |
| 13 Oct 2026 | $0.15 | $-0.01 | -6.67% | 206,566 | $0.15 | $0.15 | $0.14 |
| 12 Oct 2026 | $0.15 | $0.01 | 6.90% | 715,111 | $0.15 | $0.15 | $0.14 |
| 09 Oct 2026 | $0.15 | $0.00 | 0.00% | 732,979 | $0.15 | $0.15 | $0.14 |
| 08 Oct 2026 | $0.14 | $0.00 | 0.00% | 275,203 | $0.15 | $0.15 | $0.14 |
| 07 Oct 2026 | $0.15 | $0.00 | 0.00% | 838,708 | $0.15 | $0.15 | $0.14 |
| 06 Oct 2026 | $0.15 | $0.00 | 0.00% | 447,288 | $0.14 | $0.15 | $0.14 |
| 05 Oct 2026 | $0.14 | $0.00 | 0.00% | 80,912 | $0.14 | $0.15 | $0.14 |
| 02 Oct 2026 | $0.14 | $0.00 | 0.00% | 82,739 | $0.14 | $0.15 | $0.14 |
| 01 Oct 2026 | $0.14 | $0.00 | 0.00% | 406,901 | $0.14 | $0.15 | $0.14 |
| 30 Sep 2026 | $0.14 | $0.00 | 0.00% | 428,477 | $0.14 | $0.14 | $0.14 |
| 29 Sep 2026 | $0.14 | $0.00 | 0.00% | 417,195 | $0.14 | $0.14 | $0.14 |
| 28 Sep 2026 | $0.14 | $0.01 | 7.41% | 338,978 | $0.14 | $0.14 | $0.14 |
| 25 Sep 2026 | $0.14 | $-0.01 | -7.14% | 971,580 | $0.15 | $0.15 | $0.14 |
| 24 Sep 2026 | $0.14 | $0.00 | 0.00% | 259,998 | $0.14 | $0.14 | $0.14 |
| 23 Sep 2026 | $0.14 | $0.00 | 0.00% | 597,010 | $0.14 | $0.14 | $0.14 |
| 22 Sep 2026 | $0.14 | $0.00 | 0.00% | 140,695 | $0.14 | $0.14 | $0.14 |
Director Transactions Data provided by Morningstar.
| Date | Director | Type | Amount | Value | Notes |
|---|---|---|---|---|---|
| 28 Aug 2026 | Carmen Riley | Expiry | 2,247,877 | $309,083 |
As advised by the company. 2,247,877 - Lapsed; 11,229,286 - Rights
|
| 03 Jul 2026 | Carmen Riley | Issued | 5,996,911 | $929,521 |
Issue of securities. 13,477,163 Performance Rights
|
| 30 Jun 2026 | John Walstab | Sell | 6,000,000 | $780,000 |
Off-market trade.
|
| 30 Jun 2026 | John Walstab | Buy | 6,000,000 | $780,000 |
Off-market trade.
|
| 29 Jun 2026 | Peter Egglestone | Buy | 200,000 | $26,980 |
On-market trade.
|
| 30 Dec 2025 | David Collins | Buy | 2,000,000 | $438,400 |
On-market trade.
|
| 22 Dec 2025 | Carmen Riley | Buy | 2,000,000 | $360,000 |
On-market trade.
|
| 19 Dec 2025 | David Collins | Buy | 3,000,000 | $541,200 |
On-market trade.
|
| 19 Dec 2025 | John Walstab | Buy | 1,000,000 | $180,000 |
On-market trade.
|
| 09 Dec 2025 | Carmen Riley | Buy | 100,000 | $23,612 |
On-market trade.
|
| 08 Dec 2025 | Carmen Riley | Issued | 3,018,108 | $709,255 |
Issue of securities.
|
| 07 Nov 2025 | John Walstab | Transfer | 15,000,000 | $4,875,000 |
As advised by the company. Off-market transfer of 15,000,000 Shares to HSBC Custody
Nominees (Australia) Limited as custodian for Equities First Holdings LLC pursuant to the Master Loan Agreement and Deed of Security |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Mr Peter Andre Lacaze | Non-Executive ChairmanNon-Executive Director | Jun 2024 |
Mr Lacaze became the Chairman of CH2 Holdings in December 2015. As an experienced Australian business leader, Peter has worked in several industries with particular emphasis on healthcare and travel. He is a Member of the Risk Committee.
|
| Mr Michael Sapountzis | Company Secretary | Nov 2024 |
--
|
| Ms Carmen Rose Riley | Chief Operating OfficerExecutive Director | Jun 2024 |
Ms Riley joining CH2 Holdings Carmen was CEO of PQ Lifestyles (Intouch) from July 2008, which was acquired by CH2 Holdings in 2010. Prior to joining the Healthcare industry Carmen had a career within FMCG, including Supply Chain and Operations, Finance and Project Management. Carmen's experience provides financial and operational management skills obtained from both private and listed companies.
|
| Mr David Keith Collins | Chief Executive OfficerManaging Director | Jun 2024 |
Mr Collins was appointed as CEO and Managing Director in December 2015 of CH2 Holdings when David and Peter Lacaze acquired 100% of CH2 Holdings. David has been with CH2 Holdings since 2005 and moved to Executive Director Mergers & Acquisitions in 2026. David spent 14 months as the Chief Financial Officer at Greencross Health Limited in Auckland. David brings experience and knowledge of the Australian and New Zealand healthcare wholesale and distribution sectors.
|
| Mr Peter John Egglestone | Non-Executive Director | Mar 2025 |
Mr Egglestone is a senior executive and has more than 25 years of leadership, financial and commercial experience. Peter is the CEO and Managing Director of Aero Travel Solutions Pty Limited, a travel ticketing technology company. In addition, Peter has held several C-Suite positions including for private equity business Journey Beyond, where he led all revenue functions, including sales, marketing, revenue management and customer relations. Peter has a finance and economics background having spent many of his formative years in Corporate and Statutory Accounting. He is the Chair of the Risk Committee.
|
| Brendon Pentland | CFO |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| David Keith Collins & Cherie Maria Millar <Collins Millar Family> | 477,507,317 | 28.85% |
| Peter Andrew Lacaze & Dianne Maree Lacaze <Lacaze Family> | 472,507,317 | 28.55% |
| HSBC Custody Nominees (Australia) Limited | 154,059,591 | 9.31% |
| Mr John Andrew Walstab | 122,956,314 | 7.43% |
| J P Morgan Nominees Australia Pty Limited | 51,159,373 | 3.09% |
| BNP Paribas Nominees Pty Ltd | 30,053,279 | 1.82% |
| First Samuel Ltd Acn 086243567 | 16,989,331 | 1.03% |
| BNP Paribas Nominees Pty Ltd i | 11,556,350 | 0.70% |
| Phillip Graham Sidney Pty Ltd | 7,551,728 | 0.46% |
| Citicorp Nominees Pty Limited | 6,510,667 | 0.39% |
| Walstab Pty Limited | 6,000,454 | 0.36% |
| Snowball Fiduciary Pty Ltd | 5,329,000 | 0.32% |
| HSBC Custody Nominees (Australia) Limited A/C 2 | 4,751,141 | 0.29% |
| Dixson Trust Pty Limited | 4,506,994 | 0.27% |
| Mrs Sandra Joan Mcdonald & Mr Andrew Mcdonald | 4,502,524 | 0.27% |
| Rathvale Pty Limited | 4,152,250 | 0.25% |
| Mr Richard Albarran | 3,942,129 | 0.24% |
| Mr Drew Townsend | 3,942,128 | 0.24% |
| Jmt Investment Group Vic Pty Ltd | 3,900,000 | 0.20% |
| Mr Richard Albarran A/C 2 | 3,760,288 | 0.23% |
